Gastrointestinal Disorders | Free Full-Text | Prognostic Impact of TP53 Mutations and Tumor Mutational Load in Colorectal Cancer
Prognostic value of TP53 mutation location in breast cancer | CMAR
Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages - Behring - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Mutational processes shape the landscape of TP53 mutations in human cancer | Nature Genetics
Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties | Science Translational Medicine
The p53 network: cellular and systemic DNA damage responses in cancer and aging: Trends in Genetics
TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife
Frequency of p53 mutations in human cancers. (A) Schematic picture... | Download Scientific Diagram
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Mutations in TP53 and other heterogeneous genes help to distinguish metastases from new primary malignancies | medRxiv
Targeting a neoantigen derived from a common TP53 mutation | Science
Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome: Cell
IJMS | Free Full-Text | Do Mutations Turn p53 into an Oncogene?
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm | ACS Chemical Biology
TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors - Kim - 2023 - Cancer Medicine - Wiley Online Library
High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer | Experimental & Molecular Medicine
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma | NEJM
